A Phase II Trial of Rituximab in MG is being conducted at multiple locations in the U.S. The study is being led by Dr. Richard J. Nowak at Yale University School of Medicine. It is a multi-center randomized, double-blind, placebo-controlled clinical trial. The study is coordinated by NeuroNEXT, the Network for Excellence in Neuroscience Clinical… Read more »